Acura Pharmaceuticals, Inc. ACUR
OTC PK
| 09/30/2021 | 06/30/2021 | 03/31/2021 | |||
|---|---|---|---|---|---|
| Net Income | 61.36% | -225.65% | 56.47% | ||
| Total Depreciation and Amortization | 35.00% | -10.00% | -72.73% | ||
| Total Amortization of Deferred Charges | -- | -- | -- | ||
| Total Other Non-Cash Items | 66.67% | 222.22% | -- | ||
| Change in Net Operating Assets | 295.19% | 118.77% | -136.18% | ||
| Cash from Operations | 135.05% | 56.01% | -190.20% | ||
| Capital Expenditure | -- | -- | -- | ||
| Sale of Property, Plant, and Equipment | -- | -- | -- | ||
| Cash Acquisitions | -- | -- | -- | ||
| Divestitures | -- | -- | -- | ||
| Other Investing Activities | -- | -- | -- | ||
| Cash from Investing | -- | -- | -- | ||
| Total Debt Issued | -- | -100.00% | -- | ||
| Total Debt Repaid | -- | -- | -- | ||
| Issuance of Common Stock | -- | -- | 0.00% | ||
| Repurchase of Common Stock | -- | -- | -300.00% | ||
| Issuance of Preferred Stock | -- | -- | -- | ||
| Repurchase of Preferred Stock | -- | -- | -- | ||
| Total Dividends Paid | -- | -- | -- | ||
| Other Financing Activities | -- | -- | -- | ||
| Cash from Financing | -- | -100.00% | 26,000.00% | ||
| Foreign Exchange rate Adjustments | -- | -- | -- | ||
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | ||
| Net Change in Cash | 85.69% | -12.79% | -114.94% | ||